Here we present evidence for modulating effects exerted by FGFR1 secondary mutations on recurrent hotspot oncogenic mutations, which combined could provide a tolerated level of FGFR1 signaling required during brain development and, on the other hand, trigger oncogenic processes that cause early-onset tumor formation. Here, FGFR1 is linked to neoplasm.